Clorazepic Acid
Back to searchMolecule Structure
Scientific Name
Clorazepic Acid
Description of the Drug
Clorazepic acid is a benzodiazepine used to treat anxiety, partial seizures, and alcohol withdrawal.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00628
http://www.drugbank.ca/drugs/DB00628
Brand Name(s)
Not Available
Company Owner(s)
Dava Pharmaceuticals Inc, Watson Laboratories Inc, Alra Laboratories Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Aurolife Pharma Llc, Able Laboratories Inc, Novitium Pharma Llc, Rising Pharma Holdings Inc, Lederle Laboratories Div American Cyanamid Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1649064 | SCHEMBL21244066 | ||
| PharmGKB | PA164749297 | |||
| Human Metabolome Database | HMDB0014766 | |||
| DrugBank | DB00628 | |||
| PubChem: Thomson Pharma | 14950450 | |||
| PubChem | 2809 | |||
| Nikkaji | J20.289D | |||
| EPA CompTox Dashboard | DTXSID20863674 | |||
| DrugCentral | 711 | |||
| Guide to Pharmacology | 7548 | |||
| rxnorm | TRANXENE | CLORAZEPIC ACID | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE |
| KEGG Ligand | C06921 | |||
| ChEBI | 3761 |
